Neuropathic pain

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

Retrieved on: 
Lunedì, Settembre 17, 2018
Pain, Perception, Nociception, Acute pain, Neuropathic pain, RTT, Chronic pain, Pain management, Fibromyalgia, Postherpetic neuralgia, Opioid, Joseph J. Marbach

It offers a high-level view on the likely evolution of the non-opioid drugs and pain management devices market, in the mid-long term.

Key Points: 
  • It offers a high-level view on the likely evolution of the non-opioid drugs and pain management devices market, in the mid-long term.
  • Chapter 8 includes information on close to 120 devices that are currently approved / under investigation for the treatment / management of chronic pain.
  • Chapter 9 provides a comprehensive 2X2 analysis featuring a comparative overview of all the available / under development devices for chronic pain management.
  • Majority of the drugs (54%) are being developed for management of neuropathic pain (which includes indications such as diabetic neuropathic pain, post-herpetic neuralgia, fibromyalgia, cancer-related neuropathic pain, and HIV-related neuropathic pain).

Global Market Study on Neuropathic Pain Management: Tricyclic Anti-depressants Drug Class Segment Projected to Witness Highest Growth Through 2026

Retrieved on: 
Giovedì, Agosto 16, 2018
Pain, Perception, Acute pain, Palliative care, Nociception, Neuropathic pain, Pain management

The primary objective of the report is to offer updates and information related to market opportunities in the global neuropathic pain management market.

Key Points: 
  • The primary objective of the report is to offer updates and information related to market opportunities in the global neuropathic pain management market.
  • The Neuropathic Pain Management Market is Segmented as Follows:
    This report covers the global neuropathic pain management market performance in terms of revenue contribution from various segments.The report begins with an overview of the neuropathic pain management and its definitions.
  • The market viewpoints section underlines macro-economic factors influencing the growth of the neuropathic pain management market along with detailing its opportunity analysis.
  • The global neuropathic pain management market is segmented based on drug class, indication, distribution channel and region.

Global Pain Management Devices Market to Grow at a CAGR of 7.60% by 2023, Says TMR

Retrieved on: 
Martedì, Luglio 17, 2018
Pain, Perception, Pain management, Acute pain, Neurotechnology, Medical equipment, Neuropathic pain, Transcutaneous electrical nerve stimulation, Transparency Market Research

Transparency Market Research (TMR), after a thorough analysis of market dynamics, predicted that the global pain management devices market would grow at a healthy CAGR of 7.60%over the period between 2015 and 2023.

Key Points: 
  • Transparency Market Research (TMR), after a thorough analysis of market dynamics, predicted that the global pain management devices market would grow at a healthy CAGR of 7.60%over the period between 2015 and 2023.
  • Furthermore, the global market for pain management devices is expected to accumulate revenues worth US$ 6.3 bn by the turn of 2023.
  • Hence, the demand within the global market for pain management devices has been escalating at a robust rate over the past decade.
  • Request a Sample of Pain Management Devices Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    The review is based on TMR's report titled "Pain Management Devices Market (Devices - Stimulators, Pumps, and TENS; Application - Cancer, Musculoskeletal, and Neuropathic Pain) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023".

Global Pain Therapeutics Report 2017-2027: Latest Concepts of Pathomechanisms of Pain as a Basis for Management and Development of New Pharmacotherapies for Pain

Retrieved on: 
Mercoledì, Maggio 16, 2018
Pain, Perception, Health, Pharmacology, Pharmacy, Acute pain, Nociception, Pharmacogenomics, Pharmacogenetics, Neuropathic pain, Cancer pain

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain.

Key Points: 
  • This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain.
  • Major segments of the pain market are arthritis, neuropathic pain and cancer pain.
  • Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials.
  • Advances in pharmacogenomics and pharmacogenetics are enabling the development of personalized approaches to the management of pain.

Global Neuropathic Pain Market 2018-2024: Market Remained Stagnant Over Recent Years Due to Lack of Innovation

Retrieved on: 
Lunedì, Maggio 14, 2018
Pain, Perception, Medicine, Nervous system, Neuropathic pain, Neuralgia, Peripheral neuropathy, Postherpetic neuralgia, EMA401, Chronic wound pain

The "Neuropathic Pain Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Neuropathic Pain Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering.
  • Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory system, resulting in symptoms that include burning, stabbing, shooting, or electric shock-like sensations, which substantially differentiate it from nociceptive pain.
  • Neuropathic pain is not a single disease, but a syndrome caused by an array of different diseases and lesions, with common subtypes such as diabetic peripheral neuropathy, post-herpetic neuralgia, and chemotherapy-induced neuropathic pain.
  • Treatment of neuropathic pain has remained stagnant over recent years due to lack of innovation within the pain market.

Global Neuropathic Back Pain Epidemiology and Patient Flow Analysis 2017-2026

Retrieved on: 
Mercoledì, Aprile 18, 2018
Perception, Pain, Nociception, Acute pain, Suffering, Back pain, Neuropathic pain, Chronic pain

The "Global Neuropathic Back Pain Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Neuropathic Back Pain Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
  • The research provides insights into Neuropathic Back Pain epidemiology, Neuropathic Back Pain diagnosed patients, and Neuropathic Back Pain treatment rate for US, Japan, and EU5 countries.
  • The research measures key indicators including prevalence of Neuropathic Back Pain derived from epidemiological analysis, patients diagnosed with Neuropathic Back Pain, and patients treated with a drug therapy.
  • The research provides estimates and forecasts of Neuropathic Back Pain prevalence, Neuropathic Back Pain diagnosis rate, and Neuropathic Back Pain treatment rate for the period 2017 - 2026.